Wang resin catalysed sonochemical synthesis of pyrazolo[4,3-d]pyrimidinones and 2,3-dihydroquinazolin-4(1H)-ones: Identification of chorismate mutase inhibitors having effects on Mycobacterium tuberculosis cell viability

ElsevierVolume 134, May 2023, 106452Bioorganic Chemistry

Dedicated to Professor Seyed E. Hasnain (National Science Chair, Indian Institute of Technology, Delhi, India) on the occasion of his 69th birthday (April 13, 1954)

Author links open overlay panel, , , , , , , , , , , Highlights•

Pyrazolopyrimidinones and quinazolinones were explored as inhibitors of CM.

These compunds were accessed via a Wang resin catalysed sonochemical method.

Among them, 3b and 3c interacted with and inhibited MtbCM in silico and in vitro.

They decreased the Mtb cell viability without affecting mammalian cells significantly.

Being first example of CM inhibitors to show such effects they are of further interest.

Abstract

The enzyme chorismate mutase (or CM that is vital for the survival of bacteria) is an interesting pharmacological target for the identification of new anti-tubercular agents. The 5,5-disibstituted pyrazolo[4,3-d]pyrimidinone derivatives containing the fragment based on 4-amino-1-methyl-3-propyl-1H-pyrazole-5-carboxamide were designed and explored as the potential inhibitors of chorismate mutase. Based on encouraging docking results of two representative molecules evaluated in silico against MtbCM (PDB: 2FP2) the Wang resin catalysed sonochemical synthesis of target N-heteroarenes were undertaken. The methodology involved the reaction of 4-amino-1-methyl-3-propyl-1H-pyrazole-5-carboxamide with the appropriate cyclic/acyclic ketones to afford the desired products in acceptable (51–94%) yields. The methodology was also extended successfully towards the synthesis of 2,2-disubstituted 2,3-dihydroquinazolin-4(1H)-ones in excellent (85–90%) yields. In vitro MTT assay against the RAW 264.7 cell line followed by enzymatic assay against MtbCM identified 3b and 3c as active compounds that showed two H-bonding via their NH (at position 6) and Cdouble bondO group with MtbCM in silico and encouraging (54–57%) inhibition at 30 µM in vitro. Notably, none of the 2,2-disubstituted 2,3-dihydroquinazolin-4(1H)-ones showed any significant inhibition of MtbCM suggesting the favourable role of the pyrazole moiety in case of pyrazolo[4,3-d]pyrimidinones. The favourable role of cyclopentyl ring attached to the pyrazolo[4,3-d]pyrimidinone moiety and that of two methyl groups in place of cyclopentyl ring was also indicated by the SAR study. Besides showing effects against MtbCM in the concentration response study, 3b and 3c showed little or no effects on mammalian cell viability up to 100 µM in an MTT assay but decreased the % Mtb cell viability at 10–30 µM with > 20% decrease at 30 µM in an Alamar Blue Assay. Moreover, no adverse effects were noted for these compounds when tested for teratogenicity and hepatotoxicity in zebrafish at various concentrations. Overall, being the only example of MtbCM inhibitors that showed effects on Mtb cell viability the compound 3b and 3c are of further interest form the view point of discovery and development of new anti-tubercular agents.

Keywords

Wang resin

N-heteroarenes

Chorismate mutase

Mycobacterium tuberculosis

AbbreviationsN-heteroarenes

Nitrogen heteroarenes

Data availability

Data are presented either in the manuscript or in the suppl data

View full text

© 2023 Elsevier Inc. All rights reserved.

留言 (0)

沒有登入
gif